SMTL ID : 8g3e.2 (1 other biounit)

Crystal structure of human WDR5 in complex with (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide (compound 2, WDR5-MYC inhibitor)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.33 Å

Oligo State

monomer

Ligands

1 x YJR: (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide(Non-covalent)

YJR.1: 11 residues within 4Å: Chain A: R.163, S.205, P.206, N.207, Y.210, L.231, F.248, V.250, K.254, L.270, Q.271 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:P.206, A:Y.210, A:Y.210, A:L.231, A:L.270, A:L.270 Hydrogen bonds: A:R.163, A:N.207, A:N.207, A:K.254

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ding, J. et al., Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction. J.Med.Chem. (2023)

Release Date

2023-06-28

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

WD repeat-containing protein 5

Related Entries With Identical Sequence